Item specifics

Condition:
New: A brand-new, unused, unopened and undamaged item in original retail packaging (where packaging is ... Read moreabout the condition
Brand: Klarfit
Top Features: inflatable paddle board,stand up,excursion,SUP,320x12x81,green MPN: FITN2-Spreestar 320
Highlights: inflatable paddle board,PVC,transport bag,safety foot tie,surfing ean: 4260509688888
Included: inflatable paddle board,Pump,Repair kit,Fin,telescopi paddle,rope EAN: 4260509688888
Inflatable Paddle Stand Up SUP Board Set 320x12x81 Green Pump Bag Rope

Nationally Ranked Specialties

Asics Gel Resolution 7 Mid Nera-blue All Court

Building Update

Building Elevated View

University of Iowa Stead Family Children’s Hospital is designed as a healing environment that improves the health and well-being of children and their families. Plans include expanding existing programs and developing new services on-site and throughout Iowa to meet the current and future needs of Iowa’s children.

16lb Hammer FLAWLESS Pearl Reactive Bowling Ball & Hammer Shammy Pad

News

= 16.13 Blast from the Past 1986 Star Trak REACTOR Urethane Red Solid

SEADOO JETSKI redAX 800 (787) NEW CYLINDER HEAD,BOMBARDIER BRP.

University of Iowa Stead Family Children’s Hospital joins a group of more than 30 sites across the country committed to using research and education to help prevent injury to children.

Connelly Lotus Wakeboard 2018 - 134 cm

Join us on Friday, July 12 at University of Iowa Health Care - Iowa River Landing for a bike safety event geared to the whole family.

Edward Bell receives mentor award from Pediatric Academic Societies

Rev-X Cobra Wine Bowling Wrist Supports Accessories Accessary Left Hand_AC

Edward Bell, MD, a neonatologist at University of Iowa Stead Family Children’s Hospital, has been awarded the Maureen Andrew Mentor Award from the Society of Pediatric Research, following his 40 years in pediatric medicine.

UI study suggests new approach to treating kids with relapsed cancer

14lb 900 Global EON INFINITE Hybrid Reactive Bowling Ball

UI researchers led by Miles Pufall, PhD, have identified a new target that may help improve treatment for children with relapsed B-cell acute lymphoblastic leukemia (B-ALL), the most common type of childhood cancer.